← Back to Clinical Trials
Recruiting NCT06356558

NCT06356558 Adapting Enhanced Recovery Programs for Low Health Literacy Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06356558
Status Recruiting
Phase
Sponsor University of Alabama at Birmingham
Condition Surgery
Study Type INTERVENTIONAL
Enrollment 1,050 participants
Start Date 2026-06-15
Primary Completion 2027-08-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Educational intervention (VISACT)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 1,050 participants in total. It began in 2026-06-15 with a primary completion date of 2027-08-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Low health literacy patients are a vulnerable population at high-risk for surgical disparities including longer hospital stays, more complications, and more readmissions. This study will adapt enhanced recovery programs (ERPs) to low health literacy patients with a multilevel, health literacy-based implementation strategy (called VISACT - VISuAl aids, Coach providers in communication, and Train organizations in health literacy) to improve ERP fidelity and thereby outcomes. In the final aim of this project (Specific Aim 3), the VISACT intervention will be tested in a pilot trial. Findings from this study will lay the foundation for a multi-institutional stepped-wedge trial and establish key principles for adapting interventions to eliminate disparities.

Eligibility Criteria

Inclusion Criteria: * Adult patients \>= 18 years of age undergoing surgery under an enhanced recovery program (ERPs) * Adult caregivers/providers, organizational leaders, \>= 18 years of age with direct or indirect involvement with ERP implementation * All genders * All race/ethnicities * Able to consent * English-speaking Exclusion Criteria: * Child (\<18 years of age) * Patients undergoing operations not included under ERPs * Participants unable to consent for the study * Participants whose mental state excludes them from being able to understand contents of the informed consent form and/or patients whose family members or patient representative do not wish for them to participate in the study

Contact & Investigator

Central Contact

Daniel I Chu, MD

✉ dchu@uab.edu

📞 205-975-1932

Principal Investigator

Daniel I Chu, MD

PRINCIPAL INVESTIGATOR

University of Alabama at Birmingham

Frequently Asked Questions

Who can join the NCT06356558 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06356558 currently recruiting?

Yes, NCT06356558 is actively recruiting participants. Contact the research team at dchu@uab.edu for enrollment information.

Where is the NCT06356558 trial being conducted?

This trial is being conducted at Birmingham, United States.

Who is sponsoring the NCT06356558 clinical trial?

NCT06356558 is sponsored by University of Alabama at Birmingham. The principal investigator is Daniel I Chu, MD at University of Alabama at Birmingham. The trial plans to enroll 1,050 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology